1. Trang chủ
  2. » Y Tế - Sức Khỏe

Thay van động mạch chủ qua da trên bệnh nhân đông nam á (transcatheter aortic valve implantation the malaysian experience)

37 213 1
Tài liệu được quét OCR, nội dung có thể không chính xác

Đang tải... (xem toàn văn)

Tài liệu hạn chế xem trước, để xem đầy đủ mời bạn chọn Tải xuống

THÔNG TIN TÀI LIỆU

Thông tin cơ bản

Định dạng
Số trang 37
Dung lượng 3,05 MB

Nội dung

Trang 1

ROSLI Mohd AliHead

Department of CardiologyNational Heart Institute

Kuala Lumpur

Trang 5

31% of patients with severe

Trang 7

Edward Sapien Valve

Trang 8

CoreValve

Self-expanding nitinol frame & porcine pericardiumLength 50 mm, 18 Fr = 6 mm

Trang 10

Evolution of Self-Expanding TAVI

The CoreValve clinical experience includes three product generations:

• 1st generation (25F) - Proof of concept

• 2nd generation (21F) - Safety & efficacy study

• 3rd generation (18F) - Safety & efficacy study + Post CE Registry

Evolution to Truly Percutaneous AVR

Trang 11

ProSTAR (Abbott)

Trang 12

1st Patient – Femoral Artery Access

Trang 16

Partner Cohort B

50.7%

Trang 18

Partner Cohort A

Trang 20

Patient Selection is Critical !TAVI

Need to ensure a successful programmePatient safety & clinical benefits

Outcome data (under scrutiny)Cost issues (funding)

Trang 21

TAVIClinical AssessmentSevere symptomatic ASElderly age groupGeneral condition

General well being before being symptomatic

Trang 23

Echocardiography (required)

Trang 24

Annulus – LVOT measurement

annulusLVOT

height

Annulus diameter 20 – 27 mm

Trang 26

Coronary Angiogram

Severe stenosis in proximal segment Should be treated prior to TAVI

Trang 31

IJN Experience:Baseline characteristics (n=16) •VariablesPatientsMean age76 ± 4 Sex male (%)13 (81%)

Mean body mass index25.98 ± 8

Coronary artery disease10 (62.5%)

Hypertension10 (62.5%)

Diabetes Mellitus3 (18.8%)

Chronic renal failure2 (12.5%)

Anaemia + Chronic Myeloid Leukaemia3 (18.8%)Others (chronic lung disease, previous

cancer, Atrial Fibrillation, Myaesthenia

Trang 32

Baseline characteristics

VariablesNo

Mean functional class (NYHA)2.3 ± 0.8Echo :

Mean aortic valve area (cm)0.57 ± 0.13 Mean aortic peak gradient

(mmHg)

97 ± 28

Mean ejection fraction (%)61 ± 8

Trang 37

Conclusions

•The transcatheter aortic valve replacement

programme requires a dedicated & committed TEAM approach

•Attention to detail at every juncture is crucial

for a successful programme

•Has a steep and in-depth learning curve

Ngày đăng: 04/10/2015, 12:25

TÀI LIỆU CÙNG NGƯỜI DÙNG

TÀI LIỆU LIÊN QUAN

w